Keystone Symposia

This meeting took place in 2020



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities (J4)


Organizer(s) Cigall Kadoch and Christopher Vakoc
January 26—30, 2020
Keystone Resort • Keystone, CO USA
Discounted Abstract Deadline: Oct 1, 2019
Abstract Deadline: Oct 29, 2019
Scholarship Deadline: Oct 1, 2019
Discounted Registration Deadline: Nov 26, 2019

Sponsored by Incyte Corporation


Summary of Meeting:
The 2020 Keystone Symposia, Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities, in conjunction with the joint conference, Gene Regulation: From Mechanisms to Disease, co-organized by Karen Adelman and Patrick Cramer, will highlight state-of-the art advances in methods, mechanistic insights, and drug discovery efforts across these interrelated fields. Furthermore, results from exome- and genome-wide sequencing efforts point toward major roles for chromatin regulatory machinery in cancer. These data emphasize the immediate need for mechanistic understanding and, in parallel, the identification of novel strategies toward therapeutic targeting for this class of cancer drivers. This conference will help to foster interactions and new connections between basic biologists focused on chromatin architecture, structure, and function with translational biologists focused on model systems for mechanistic interrogation. Participants will attend sessions that will feature the presentation of new methods and techniques in systems biology, imaging, genomics, and drug discovery approaches. Other topics will explore the roles for enhancer structure, genome organization and topology on DNA accessibility and gene expression. Finally, this conference will expose trainees across a wide range of international, interdisciplinary laboratories to cutting edge science in cancer epigenetics and related fields, hoping to further their interests and commitment to this area of biologic research. The concurrent joint conference on 'Gene Regulation: From Mechanisms to Disease' is another unique, one-of-a-kind aspect of this conference, allowing participants to attend talks in their area of interest across two closely-related disciplines. Our cancer-centered audience will have an opportunity to attend select talks as well as two joint sessions, which all the organizers have carefully considered and designed together.

View Meeting Program

Scholarships/Awards


Keystone Symposia Future of Science Fund Scholarship Recipients


Menuka Karki
Baylor College of Medicine, USA

Amber Louwagie
Ghent University, Belgium

KS/ABRCMS Travel Award Recipients


Antja-Voy Hartley
Indiana University School of Medicine, USA

National Cancer Institute (NCI) Scholarship Recipients


Allyson M. Freedy
Harvard University, USA

Noa Furth
Weizmann Institute of Science, Israel

Nicholas C. Gomez
Rockefeller University, USA

Kelsey Simone Johnson
Baylor University, USA